Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea. [electronic resource]
Producer: 20200527Description: 432-446 p. digitalISSN:- 2233-6079
- Aged
- Blood Glucose -- analysis
- Body Weight -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- adverse effects
- Insulin Glargine -- adverse effects
- Male
- Metformin -- adverse effects
- Middle Aged
- Sulfonylurea Compounds -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.